Labcorp stock gained 1.28 percent before October 28 results
Published on 10/04/2026 at 22:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp (ISIN US5049221055) was last at USD 308.49 on the NYSE on October 2, 2026, up 1.28 percent from the prior session. The company is heading toward its next scheduled results date, with Labcorp announcing on September 30, 2026, that third-quarter results will be released on October 28, 2026.
Revenue reaches USD 3.73 billion
Labcorp generated quarterly revenue of USD 3.73 billion, up 5.8 percent from the same period a year earlier, according to MarketBeat on October 1, 2026. The comparison gives the stock a concrete operating anchor while the market price remains below its 52-week high of USD 341.80.
The same quarterly report cited by MarketBeat put earnings per share at USD 4.99 against consensus of USD 4.78. That USD 0.21 beat adds a second comparison to the revenue growth and helps explain why analyst coverage remains constructive.
Guidance meets reimbursement pressure
Labcorp reaffirmed its 2026 to 2029 outlook in a September 22, 2026, filing carried by StockTitan. The plan targets compound annual revenue growth of 5 percent to 8 percent, adjusted operating margin expansion of 75 to 150 basis points by the end of 2029, and adjusted EPS growth of 8.5 percent to 11.5 percent.
The counter-factor is regulatory pricing. Labcorp said preliminary CMS laboratory fee rates for 2027 through 2029 could impose steep annual payment cuts under PAMA, while the company continues evaluating the impact on future guidance.
Stock remains below yearly high
At USD 308.49, Labcorp's share price stood USD 33.31 below the 52-week high and USD 63.97 above the 52-week low of USD 244.52, both measured on October 2, 2026. The company had a market capitalization of USD 25.3 billion and volume of 586,944 shares on that date.
For investors, the central tension is visible in the numbers: quarterly revenue growth and the reaffirmed multi-year plan contrast with reimbursement uncertainty ahead of the 2027 rate period.
Labcorp stock heads into October results
Labcorp stock was last at USD 308.49 on the NYSE on October 2, 2026, with the next scheduled report set for October 28, 2026.
Labcorp stock key facts
- Company: Labcorp Holdings Inc.
- ISIN: US5049221055
- Ticker: LH
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 308.49
- Market capitalization: USD 25.3 billion (as of October 2, 2026)
- 52-week range: USD 244.52-341.80 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Diagnostics and Research
Upcoming dates for Labcorp stock
- October 28, 2026: Third-quarter 2026 financial results
